HUDA
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
47.7M
RENEU
Price
$11.69
Change
-$0.05 (-0.43%)
Updated
Feb 19 closing price
Capitalization
N/A
Ad is loading...

HUDA vs RENEU

Header iconHUDA vs RENEU Comparison
Open Charts HUDA vs RENEUBanner chart's image
Hudson Acquisition I
PriceLoading...
Change-$0.00 (-0.00%)
VolumeN/A
Capitalization47.7M
Cartesian Growth
Price$11.69
Change-$0.05 (-0.43%)
Volume$100
CapitalizationN/A
HUDA vs RENEU Comparison Chart
Loading...
View a ticker or compare two or three
VS
HUDA vs. RENEU commentary
Mar 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HUDA is a StrongBuy and RENEU is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 05, 2025
Stock price -- (HUDA: $12.56 vs. RENEU: $11.69)
Brand notoriety: HUDA and RENEU are both not notable
Both companies represent the Financial Conglomerates industry
Current volume relative to the 65-day Moving Average: HUDA: 100% vs. RENEU: 20%
Market capitalization -- HUDA: $47.7M vs. RENEU: $0
HUDA [@Financial Conglomerates] is valued at $47.7M. RENEU’s [@Financial Conglomerates] market capitalization is $0. The market cap for tickers in the [@Financial Conglomerates] industry ranges from $590.24B to $0. The average market capitalization across the [@Financial Conglomerates] industry is $3.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HUDA’s FA Score shows that 1 FA rating(s) are green whileRENEU’s FA Score has 0 green FA rating(s).

  • HUDA’s FA Score: 1 green, 4 red.
  • RENEU’s FA Score: 0 green, 5 red.
According to our system of comparison, both HUDA and RENEU are a bad buy in the long-term.

Price Growth

HUDA (@Financial Conglomerates) experienced а 0.00% price change this week, while RENEU (@Financial Conglomerates) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Financial Conglomerates industry was -0.27%. For the same industry, the average monthly price growth was +2.26%, and the average quarterly price growth was +3.93%.

Industries' Descriptions

@Financial Conglomerates (-0.27% weekly)

Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.

FUNDAMENTALS
Fundamentals
RENEU YTD gains are higher at: 0.516 vs. HUDA (0.000). HUDA has higher annual earnings (EBITDA): -1.75M vs. RENEU (-2.03M). RENEU has more cash in the bank: 50.9K vs. HUDA (28.3K). HUDA has less debt than RENEU: HUDA (282K) vs RENEU (3.98M). HUDA (0) and RENEU (0) have equivalent revenues.
HUDARENEUHUDA / RENEU
Capitalization47.7MN/A-
EBITDA-1.75M-2.03M86%
Gain YTD0.0000.516-
P/E Ratio3071.99N/A-
Revenue00-
Total Cash28.3K50.9K56%
Total Debt282K3.98M7%
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHLAX34.92N/A
N/A
PGIM Jennison Health Sciences A
TIIRX26.72N/A
N/A
Nuveen Core Equity A
RYAUX50.74N/A
N/A
Rydex Utilities H
JIVRX31.45-0.30
-0.94%
JPMorgan U.S. Applied Data Sci Val R5
DGOYX41.64-0.65
-1.54%
Davis Opportunity Y